Publications Database

Accordino R. E. et al. (2016)

Psychopharmacological interventions in autism spectrum disorder.

Expert Opinion on Pharmacotherapy

May, 17(7), pp. 937-952.

Read Abstract (New Window)

Medicines And Healthcare Products Regulatory Agency (2005)

Antipsychotic medicines: licensed products, uses and side effects.

Read Full (New Window)

Akhondzadeh S. et al. (2008)

A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder.

Child Psychiatry and Human Development

39(3), pp. 237-245

Read Abstract (New Window)

Akhondzadeh S. et al. (2004)

Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.

Journal of Clinical Pharmacy and Therapeutics

29(2), pp.145-150

Read Abstract (New Window)

Akhondzadeh S. et al. (2010)

Double-blind placebo controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism.

Progress in Neuro-Psychopharmacology and Biological Psychiatry

34(1), pp. 32-36

Read Abstract (New Window)

Alexander R. , Michael D. , Ganghadaran S. (2004)

The use of risperidone in adults with Asperger syndrome.

British Journal of Learning Disabilities

50(99), pp. 109-115.

Read Abstract (New Window)

Aman M. G. et al. (2005)

Acute and long-term safety and tolerability of risperidone in children with autism.

Journal of Child and Adolescent Psychopharmacology

15(6), pp. 869-884

Read Abstract (New Window)

Aman M. G. et al. (2008)

Cognitive effects of risperidone in children with autism and irritable behavior.

Journal of Child and Adolescent Psychopharmacology

18(3), pp. 227-236

Read Abstract (New Window) Read Full (New Window)

Aman M. G. et al. (2010)

Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

20(5), pp. 415-422.

Read Abstract (New Window)

Aman M. G. (2004)

Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder.

Seminars in Pediatric Neurology

11(3), pp. 225-228

Read Abstract (New Window)

Aman M. G. et al. (2009)

Medication and parent training in children with pervasive developmental disorders and serious behavior problems: Results from a randomized clinical trial.

Journal of the American Academy of Child and Adolescent Psychiatry

48(12), pp. 1143-1154

Read Abstract (New Window) Read Full (New Window)

Aman M. G. et al. (2015)

Tolerability, safety, and benefits of risperidone in children and adolescents with autism: 21-month follow-up after 8-week placebo-controlled trial.

Journal of Child and Adolescent Psychopharmacology

August, 25(6), pp. 482-493.

Read Abstract (New Window) Read Full (New Window)

Aman M. G. , Hollway J. A. , Arnold L. E. (2008)

Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders.

Child and Adolescent Psychiatric Clinics of North America

17(4), pp. 713-738

Read Abstract (New Window)

American Society of Health-System Pharmacists (2017)

Aripiprazole.

American Society of Health-System Pharmacists

Read Full (New Window)

American Society of Health-System Pharmacists (2011)

Olanzapine.

American Society of Health-System Pharmacists

Read Full (New Window)

American Society of Health-System Pharmacists (2017)

Risperidone.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

Anagnostou E. , Hansen R. L. (2011)

Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications.

Current Opinions in Pediatrics

23(6), pp. 621-627.

Read Abstract (New Window)

Anagnostou E. et al.

Metformin for treatment of overweight induced by atypical antipsychotic medication in young people with autism spectrum disorder: A randomized clinical trial.

JAMA Psychiatry

Read Abstract (New Window)

Anderson G. M. et al. (2007)

Effects of short- and long-term risperidone treatment on prolactin levels in children with autism.

February, 61(4), pp. 545-550.

Read Abstract (New Window)

Anderson L. T. et al. (1984)

Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms

American Journal of Psychiatry

141(10), pp. 1195-1202

Read Abstract (New Window)